期刊文献+

IgA肾病患者Cosmc基因表达低下原因探讨 被引量:3

Causes of reduced expression of Cosmc gene in IgA nephropathy patients
原文传递
导出
摘要 目的探讨IgA肾病(IgAN)患者核心181,3半乳糖基转移酶伴侣蛋白(Cosmc)表达低下的原因,到底是基因突变还是外源性抑制。方法40例IgAN患者、16例非IgAN。肾小球。肾炎患者、21例健康对照被纳入本研究。直接测序方法测定Cosmc基因外显子区域的核酸序列。免疫磁珠分离IgAN患者、非IgAN肾小球肾炎患者和健康对照者外周血B淋巴细胞,并分别在RPMI-1640及RPMI—1640+脂多糖(LPS)中培养72h。实时荧光RT—PCR方法测定Cosmc基因的mRNA表达水平。结果(1)IgAN患者Cosmc基因外显子区域没有共同突变位点,仅在2例患者中发现2处错义突变和2处无意义突变,而且这些突变并不影响患者Cosmc基因的表达:(2)IgAN患者外周血B淋巴细胞的基础Cosmc基因表达显著降低,为健康对照组的31%。(3)经RPMI-1640培养后,IgAN患者Cosmc基因的表达水平升高至基础值的219%。RPMI—1640+LPS组Cosmc基因的上调受到明显抑制。(4)健康对照Cosmc基因的表达不受RPMI-1640和LPS的影响。结论IgAN患者外周血B淋巴细胞Cosmc基因表达低下可能与基因突变无关,而是受外源性抑制因素影响所致. Objective To clarify whether the Cosmc gene down-regulation in lgA nephropathy (IgAN) patients is resulted from genetic disorders or external suppressions. Methods Forty IgAN patients, 16 non-IgAN glomemlonephritis patients and 21 healthy controls were enrolled in the study. Genomic DNA was extracted and then Cosmc gene was amplified and sequenced. Peripheral B lymphocytes were isolated and cultured with RPMI-1640 alone or plus lipopolysaccharide (LPS). The Cosnw mRNA expression levels at baseline, after RPMl-1640 culture or RPMI-1640+LPS treatment were measured respectively by real-time RT-PCR. Results (1) Only 2 missense mutations and 2 silent mutations were detected in coding frame region of Cosmc gene in 2 IgAN patients. (2) The baseline Cosmc gene expression level was significantly lower in IgAN patients (31% of that in healthy controls) than that in healthy controls. (3) Relative quantification PCR indicated that Cosmc mRNA expression level was significantly increased (219% of baseline) after RPMI-1640 culture, and treatment of LPS could strongly inhibit this effect. (4) The Cosmc gene expression of healthy control was not affected by RPMI-1640 or LPS. Conclusion It is not genetic disorders but external suppression to cause the down-regulatlon of Cosmc gene mRNA expression in IgAN.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2008年第6期377-381,共5页 Chinese Journal of Nephrology
基金 四川省中医药管理局科学研究基金(2004A63) 四川省人事厅人才基金(06SXS-13)
关键词 肾小球肾炎 IGA 糖基化 脂多糖类 核心1β1 3半乳糖基转移酶伴侣蛋白基因 Glomemlonephritis, IgA Glyeosylation, Lipopolysaeeharide Cosme gene
  • 相关文献

参考文献13

  • 1Barratt J, Feehally J. IgA nephropathy. J Am Soc Nephrol, 2005,16:2088-2097.
  • 2Allen AC, Topham PS, Harper SJ, et al. Leucocyte beta 1,3 galactosyhransferase activity in IgA nephropathy. Nephrol Dial Transplant, 1997,12:701-706.
  • 3Qin w, Zhou Q, Yang LC, et al. Peripheral B lymphocyte beta1, 3-galactosyhransferase and chaperone expression in immunoglobulin A nephropathy. J Intern Med, 2005,258: 467-477.
  • 4Pfaffl MW. A mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res, 2001,29:e45.
  • 5Xu LX, Zhao MH. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int, 2005, 68:167-172.
  • 6Ju T, Cummings RD. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3- galactosyhransferase. Proc Natl Acad Sci USA, 2002,99: 16613-16618.
  • 7Ju T, Cummings RD. Protein glycosylation: chaperone mutation in Tn syndrome. Nature, 2005,437(7063):1252.
  • 8张宏.IgA肾病的分子遗传学研究[J].中华肾脏病杂志,2005,21(11):641-644. 被引量:12
  • 9吕继成,张宏,陈育青,刘刚,王海燕.家族性IgA肾病——777例中国IgA肾病回顾性调查分析[J].中华肾脏病杂志,2004,20(1):5-7. 被引量:30
  • 10聂广俊,李贵森,张宏.IgA肾病患者C1GALT1C1基因的体细胞突变筛查[J].中华肾脏病杂志,2007,23(5):288-291. 被引量:4

二级参考文献4

共引文献43

同被引文献59

  • 1Woof JM, Kerr MA. IgA function-variations on a theme. Immu- nology, 2004,113 : 175-177.
  • 2Tarelli E, Smith AC, Hendry BM, et al. Human serum IgA1 is substituted with up to six O-glyeans as shown by matrix assisted laser desorption ionisation time-of-flight mass spectrometry. Car- bohydr Res, 201)4,339 : 2329-2335.
  • 3Moldoveanu Z, Wyatt RJ, Lee JY, et al. Patients with IgA ne- phropathy have increased serum galactose-deficient IgA1 levels. Kidney Int,2007~71:1148-1154.
  • 4Moura IC, Arcos-Fajardo M, Sadaka C, et al. Glycosylation and size of IgA1 are essential for interaction with mesangial transfer- tin receptor in IgA nephropathy. J am Soe Nephrol, 2004, 15: 622-634.
  • 5Yan Y, Xu LX, Zhang JJ, et al. Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy. Clin Exp Immunol, 2006,144 .. 17-24.
  • 6Lohse S, Peipp M, Beyer T, et al. Impact of human IgA antibodies on complement-dependent cytotoxicity mediated by combinations of EGF-R-directed antibodies. Arch Immunol Ther Exp, 2010, 58 : 303-312.
  • 7Xu LX,Zhao MH. Aberrantly glycosylated serum IgA1 are close- ly associated with pathologic phenotypes of IgA nephropathy. Kidney Int, 2005,68 : 167-172.
  • 8Hastings MC, Moldoveanu Z, Julian BA, et al. Galaetose-deficient IgA1 in African Americans with IgA nephropathy: Serum levels and heritability. Clin J Am Soc Nephrol, 2010,5 : 2069-2074.
  • 9Qin W,Zhou Q,Yang LC,et al. Peripheral B lymphocyte beta 1, 3-galactosyltransferase and chaperone expression in immunoglob- ulin A nephropathy. J Intern Med,2005,258:467-477.
  • 10Allen AC, Bailey EM, Brenchley PE, et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glyeosylation: observations in three patients. Kidney Int, 2001,60: 969-973.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部